Diyabet tani ve tedavi rehberi 2017-12x21cm indd

KAYNAKÇA

---

139
TÜRKDİAB Diyabet Tanı ve Tedavi Rehberi 2017
KAYNAKÇA
Chandrashekar M Sultanpur*, Deepa K & S.Vijay Kumar. COMPREHENSIVE 
REVIEW ON HBA1C IN DIAGNOSIS OF DIABETES MELLITUS. International 
Journal of Pharmaceutical Sciences Review and Research. Volume 3, Issue 2, 
July – August 2010; 119-122
Charbonnel B, Dormandy J, Erdmann E, Massi-Benedetti M, Skene A, the 
PRO active Study Group: The Prospective Pioglitazone Clinical Trial in 
Macrovascular Events (PROactive): can pioglitazone reduce cardiovascular 
events in diabetes? Study design and baseline characteristics of 5238 patients. 
Diabetes Care 2004;27: 1647-53
Chiasson J-L, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M: 
Acarbose for prevention of type 2 diabetes mellitus: the STOP- NIDDM 
randomised trial. Lancet 2002; 359: 2072-7
Chobanian, AV, Bakris, GL, Black, HR, Cushman, WC, Green LA, Izzo JL Jr. 
Jones DW, Materson BJ, Oparil S, Wright JT Jr. Rocella EJ; Joint National 
Committee on Prevention, Detection, Evaluation and Treatment of High 
Blood Pressure. National Heart, Lung, and Blood Institute; National High 
Blood Pressure Education Program Coordinating Committee: Seventh 
Report of the Joint National Committee on Prevention, Detection, Evaluation, 
and Treatment of High Blood Pres- sure. Hypertension 2003; 42: 1206-52
Chobanian, AV, Bakris, GL, Black, HR, Cushman, WC, Green LA, Izzo JL Jr. 
Jones DW, Materson BJ, Oparil S, Wright JT Jr. Rocella EJ; National Heart, 
Lung, and Blood Institute Joint National Committee on Prevention, Detection, 
Evaluation and Treatment of High Blood Pressure; National High Blood 
Pressure Education Program Coordinating Committee: The Seventh Report 
of the Joint National Committee on Prevention, Detection, Evaluation, and 
Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289: 2560
Colagiuri R: Diabetes: a pandemic, a development issue or both? Journal of Ex- 
pert Reviews Cardiovascular Therapy 2010; 8 (3): 305-9
Colagiuri RA: Guide to National Diabetes Programmes. International 
Diabetes Federation. Brussels 2010
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, 
Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller 
JH: Primary prevention of cardiovascular disease with atorvastatin in type 
2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): 
multicentre randomized placebo- controlled trial. Lancet 2004; 364: 685-96
Conget I, Gimenez M: Glucose control and cardiovascular disease is it 
important? No. Diabetes Care, 2009; 32 (Suppl. 2): S334-6
Creager MA, Luscher TF, Cosentino F, Beckman JA: Diabetes and vascular 
disease: pathophysiology, clinical consequences, and medical therapy: